What are Multiple Antigen Peptides (MAPs)?
A Multiple Antigen Peptide (MAP) is a branched peptide dendrimer—most commonly built on a
lysine dendrimer scaffold—that displays multiple copies of a peptide epitope in a single construct
(e.g., MAP2, MAP4, MAP8). By increasing epitope density, MAP peptides can improve effective recognition
for antibody production, vaccine research, and epitope validation, often as a
carrier-free peptide immunogen. Because higher valency can introduce steric crowding, on-resin aggregation, and solubility limitations,
we align design (valency, spacers, handles), synthesis strategy, purification approach, and QC deliverables to your intended use—immunization or assay. This integrated service model reflects Bio-Synthesis’s broader peptide manufacturing capabilities, including difficult and branched peptide synthesis, custom modifications, labeling, and bioconjugation—so expectations match what’s technically realistic for each MAP format.
Bio-Synthesis provides end-to-end MAP peptide synthesis services—from sequence review and valency selection (MAP2, MAP4, MAP8),
to spacer and functional handle design, synthesis optimization, purification, and fit-for-purpose QC.
MAP projects are evaluated alongside related offerings including
Custom Peptide Synthesis, Branched Peptides, and
Peptide Bioconjugation to ensure the most practical immunogen or assay-ready construct is delivered.
ISO 9001:2015/ISO13485:2016
45+ Years of Expertise
U.S. Facilities - Texas
High-Throughput MAP Peptide Synthesis
Need a linear peptide or conjugate instead? See
Custom Peptide Synthesis and
Peptide Bioconjugation.
For ready-made options, browse Catalog Peptides.